Ryan Gierke

9.3k citations
34 papers · 5.8k indexed · 10 hit papers · h-index 20

Impact in

Papers in

    • Bacterial Infections and Vaccines 5
    • Pneumonia and Respiratory Infections 26
    • Respiratory viral infections research 20
    • Pneumocystis jirovecii pneumonia detection and treatment 8

Ryan Gierke

33 papers receiving 5.6k citations

Hit Papers

Expanded Recommendations for Use of Pneumococcal Conjugate Vaccines Among Adults Aged ≥50 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024 2025 · 26 citations
26201420262018202250010001.5k

Peers

Ryan Gierke
Comparison fields: 5 of 161
  • Modeling and Simulation 590
  • Infectious Diseases 2.2k
  • Health 546
  • Obstetrics and Gynecology 476
  • Microbiology 373
Replace Eli S. Rosenberg with:
Eli S. Rosenberg United States
Hilda Razzaghi United States
Stephanie R. Bialek United States
H. Keipp Talbot United States
Tamara Pilishvili United States
Jessica R. MacNeil United States
Michelle M. Hughes United States
Priti R. Patel United States
Adi V. Gundlapalli United States
John M. McLaughlin United States
Ryan Gierke relative to Eli S. Rosenberg United States Eli S. Rosenberg's profile →
Citations per field
00.5×1.5×1.8×
Eli S. Rosenberg · 1×
Citations per year

Countries citing papers authored by Ryan Gierke

Since Specialization
Citations

This map shows the geographic impact of Ryan Gierke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Gierke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Gierke more than expected).

Fields of papers citing papers by Ryan Gierke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Gierke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Gierke. The network helps show where Ryan Gierke may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ryan Gierke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ryan Gierke Line = papers co-authored together Ryan Gierke links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1
Expanded Recommendations for Use of Pneumococcal Conjugate Vaccines Among Adults Aged ≥50 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
Hit paper breakdown →
202526
2 202415
3 202419
4
Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
Hit paper breakdown →
202437
5
Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023
Hit paper breakdown →
202370
6 20231
7
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
Hit paper breakdown →
2022223
8 20211
9 202014
10
Geographic Differences in COVID-19 Cases, Deaths, and Incidence — United States, February 12–April 7, 2020
Hit paper breakdown →
2020343
11
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020
Hit paper breakdown →
2020992
12 202026
13 201922
14
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
Hit paper breakdown →
2019244
15 201672
16 20162
17 20161
18 2016112
19
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices.
Hit paper breakdown →
2014549
20
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2013123

About Ryan Gierke

Ryan Gierke is a scholar working on Microbiology, Epidemiology, Gastroenterology, Immunology and Infectious Diseases, having authored 34 papers that have together received 5.8k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (26 papers), Respiratory viral infections research (20 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers), Immunodeficiency and Autoimmune Disorders (7 papers), Bacterial Infections and Vaccines (5 papers), Child and Adolescent Health (4 papers), Gastroesophageal reflux and treatments (3 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Modeling and Simulation (590 citations), Infectious Diseases (2.2k citations), Health (546 citations), Obstetrics and Gynecology (476 citations) and Microbiology (373 citations). Ryan Gierke has collaborated with scholars based in United States, Gambia and Zimbabwe. Frequent co-authors include Tamara Pilishvili, Stephanie R. Bialek, Michelle M. Hughes, Tami H. Skoff, Matthew D. Ritchey, Nancy A. Chow, Aron J. Hall, Lucy A. McNamara, Cynthia G. Whitney and Nancy M. Bennett. Their work appears in journals such as MMWR Morbidity and Mortality Weekly Report, Open Forum Infectious Diseases, Clinical Infectious Diseases, The Journal of Infectious Diseases and The Pediatric Infectious Disease Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026